- Shanghai Nianxing Industrial Co., Ltd
- China
- Product Name: 2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate
- Price:
- Purity: 95.0%
- Stocking Period: 10 Day
- Contact: Huang
- Dayang Chem (Hangzhou) Co., Ltd.
- China
- Product Name: 3-BOC-3,8-DIAZABICYCLO[4.2.0]OCTANE
- Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
- Purity: 98.0%
- Stocking Period: Inquiry
- Contact: Ms Wang
928754-14-7
928754-14-7 structure
- Name: 2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate
- Chemical Name: 2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate
- CAS Number: 928754-14-7
- Molecular Formula: C11H20N2O2
- Molecular Weight: 212.289
- Create Date: 2017-03-30 10:29:42
- Modify Date: 2024-01-09 23:43:51
| Name | 2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate |
|---|---|
| Synonyms |
3,8-Diaza-bicyclooctan<3.2.1>
2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate tert-butyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate 3,8-diaza-bicyclo[4.2.0]octane-3-carboxylic acid tert-butyl ester 3,8-Diazabicyclo-<-octan 3,8-Diazabicyclo[4.2.0]octane-3-carboxylic acid, 1,1-dimethylethyl ester 3,8-Diazabicyclo[4.2.0]octane-3-carboxylic acid 1,1-dimethylethyl ester 3,8-DIAZA-BICYCLO[3.2.1]OCTANE |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 295.4±13.0 °C at 760 mmHg |
| Molecular Formula | C11H20N2O2 |
| Molecular Weight | 212.289 |
| Flash Point | 132.5±19.8 °C |
| Exact Mass | 212.152481 |
| PSA | 41.57000 |
| LogP | 0.84 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.494 |
|
~91%
928754-14-7 |
| Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; Location in patent: Page/Page column 46 ; WO 2011/050202 A1 |
|
~%
928754-14-7 |
| Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
|
~%
928754-14-7 |
| Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
|
~%
928754-14-7 |
| Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
|
~%
928754-14-7 |
| Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
|
~%
928754-14-7 |
| Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |